Key Highlights

Risk & Performance

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

2 recruiting

Phase 3

1(50.0%)

N/A

1(50.0%)

2Total

Phase 3(1)

N/A(1)

Loading network data...

Showing 5 of 5 trials

AI System for Detection and Characterization of Chronic Enteropathies

Role: collaborator

Computer-Aided Water Exchange Colonoscopy With and Without Linked-Color Imaging for Detection of Clinically Significant Serrated Lesions

Role: collaborator

The Relationship Between Belief, Expectation, and Adherence to Therapy During COVID-19 Pandemic

Role: collaborator

Different Ribavirin Dosages and Different Duration of Treatment in Combination With PegInterferon in Patients With Genotype 2 and 3 (WRITE)

Role: collaborator

Antenatal Diagnosis of Placental Attachment Disorders

Role: collaborator

All 5 trials loaded